[ICD therapy for primary prevention. The patient in the early post-infarct phase]

Area of Science:

• Cardiology
• Electrophysiology
• Clinical Medicine

Context:

• High mortality rates observed in the initial weeks following acute myocardial infarction.
• Current clinical guidelines recommend delaying prophylactic implantable cardioverter-defibrillator (ICD) implantation until at least one month post-myocardial infarction, contingent on specific risk factors.
• The optimal timing for ICD implantation after myocardial infarction remains a critical consideration in patient management.

Purpose:

• To analyze existing data regarding the timing of prophylactic ICD implantation after acute myocardial infarction.
• To evaluate the impact of the recent IRIS study on current clinical practices and guidelines.
• To provide evidence-based insights into the management of post-myocardial infarction patients at risk of sudden cardiac death.

Summary:

• The article reviews data on mortality following acute myocardial infarction and the established guidelines for ICD implantation.
• It highlights that prophylactic ICD implantation is generally advised no earlier than one month after the event, based on identified risk constellations.
• The findings of the recent IRIS study are presented, demonstrating support for the current clinical practice of delayed ICD implantation.

Impact:

• Reinforces the current clinical practice for prophylactic ICD implantation timing post-myocardial infarction.
• Provides supporting evidence for guidelines recommending delayed ICD implantation.
• Contributes to the ongoing discussion on optimizing sudden cardiac death prevention strategies in post-myocardial infarction patients.